Seoul, South Korea

Ki-ho Lee

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Dongguk University Industry-Academic Cooperation Foundation, Korea Research Institute of Bioscience and Biotechnology, Kt Corporation. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki-ho Lee. Retrieved from https://idiyas.com/inventor/ki-ho-lee-0iea316h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Inventor Ki-ho Lee: Pioneering Innovations in Wireless Communication and Cancer Treatment**

Introduction

Ki-ho Lee, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the fields of wireless communication and pharmaceutical sciences. With a total of four patents to his name, his work reflects a commitment to advancing technology and healthcare solutions.

Latest Patents

One of Ki-ho Lee's notable patents is a "Method for controlling downlink HARQ in a wireless communication system and device therefor." This invention outlines a sophisticated HARQ operation procedure that allows a terminal and a base station to communicate effectively. The method includes steps for the terminal to receive HARQ feedback bundling control information from the base station, enabling efficient transmission of bundled HARQ feedbacks based on downlink data reception results. This innovation aims to minimize uplink resource utilization while maintaining robust downlink data transmission.

Another significant patent by Ki-ho Lee focuses on "Compounds as HIF-1α inhibitors and manufacturing process thereof." This invention introduces novel compounds that inhibit HIF-1α activity, offering therapeutic benefits in preventing and treating various solid cancers, including colon and breast cancer. Additionally, these compounds show promise in addressing conditions aggravated by HIF-1α-mediated VEGFA expression, such as diabetic retinopathy and rheumatoid arthritis.

Career Highlights

Ki-ho Lee has been associated with esteemed institutions, including Dongguk University Industry-Academic Cooperation Foundation and the Korea Research Institute of Bioscience and Biotechnology. His work in these organizations has facilitated the transition of innovative research into practical applications, demonstrating his dedication to science and technology.

Collaborations

Throughout his career, Ki-ho Lee has collaborated with notable professionals, including Hwan-Mook Kim and Song-Kyu Park. These partnerships have been instrumental in fostering innovation and refining his inventions, resulting in advancements that benefit both the technology and healthcare sectors.

Conclusion

Ki-ho Lee stands out as a prominent inventor in his fields, with a demonstrated commitment to developing groundbreaking solutions in wireless communication and cancer treatment. His latest patents reflect not only his technical ingenuity but also his dedication to improving the lives of many through innovation. As he continues his work, Ki-ho Lee is sure to remain a significant figure in the landscape of modern inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…